Browse Trials
In response to COVID-19, some breast cancer trials have temporarily stopped enrolling new patients. Use the contact information in our trial listings to call or email the research site for information about a trial's status.
Visit COVID-19 & Cancer Clinical Trials on Metastatic Trial Talk for regularly updated information about clinical trials during the coronavirus pandemic.
Currently viewing trials
(Last updated: July 24, 2021)
BRCA1/2 (inherited)
Chemotherapy
Hormone Therapy
Radiation Oncology
Surgery
Surgery: Reconstruction
Targeted Therapy: All
Targeted Therapy: Anti-HER2 Therapy
Targeted Therapy: CDK Inhibitors
Targeted Therapy: PARP Inhibitors
Targeted Therapy: Tumor Mutations
Targeted Therapy: Other Targeted Therapy
Vaccines and Immunotherapy
Other Treatment
Activities
Complementary and Alternative Medicine
Decision Support
Diagnosing Breast Cancer
Genetics/Family History
Having Children
Lymphedema
Managing Side Effects
No Travel Required
Predicting Response to Treatment
Preventing Breast Cancer
Preventing Recurrence
Screening
Support/Education
Surveys/Interviews/Registries
AKT
ALK
AR
BARD1
BRCA1/2 (tumor)
BRIP1
CD205
CD70
CHEK2 or CHEK1
ESR1
FGFR
HER2/ERBB2
HLA
MET or C-Met
NTRK
PALB2
PIK3CA or PI3K
PTEN
RAD51
RAF (including BRAF)
RAS (KRAS or NRAS)
RB
ROS1
TP53
NEAREST SITE: 348 miles
USC Norris Comprehensive Cancer Center
Los Angeles,CA
VISITS: 1 visit
PHASE: NA
NCT ID: NCT01755208
Using Light-Scattering Spectroscopy in Women with Stage II-III Breast Cancer (or without Breast Cancer) Having a Mammogram at University of Southern California
Light-Scattering Spectroscopy for the Detection of Stage II-III Breast Cancer: A Pilot Study Scientific Title
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will receive the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Light-scattering spectroscopy in addition to standard of care</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Light-scattering spectroscopy (LSS) is an imaging technique that does not require the removal of tissue samples and can provide quick results.</li> <li class="seamTextUnorderedListItem">LSS may be able to identify cell abnormalities more effectively than a biopsy.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT01755208' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='http://www.ncbi.nlm.nih.gov/pubmed/17280544' target='_blank'>Journal Article: Optical Diagnostic Technology Based on Light Scattering Spectroscopy for Early Cancer Detection</a> </li></ul>
NEAREST SITE: 602 miles
Huntsman Cancer Institute
Salt Lake City,UT
VISITS: 1 visit
PHASE: II
NCT ID: NCT04252859
Using a PET/CT Scan to Find Lobular Breast Cancer Cells Before Surgery for Stage I-IV Lobular Breast Cancer
[18F]Fluoroestradiol-PET/CT Imaging of Invasive Lobular Carcinoma Scientific Title
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will receive the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">PET/CT scan using (18F) FES tracer, 1 time</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">A positron emission tomography (PET) scan is an imaging test that uses a radioactive substance called a tracer. A tracer looks for and attaches to cancer cells.</li> <li class="seamTextUnorderedListItem">Lobular breast cancer is a subtype of breast cancer. It is estimated that 10 to 15 percent of all breast cancers are lobular. </li> <li class="seamTextUnorderedListItem">Standard of care PET/CT scans that use a FDG tracer generally do not find lobular breast cancer tumors as well as they find ductal breast cancer tumors and PET/CT scans are not usually given to people with stage I-II lobular breast cancer. </li> <li class="seamTextUnorderedListItem">This imaging trial will use a tracer called (18F)Fluoroestradiol (FES). Researchers believe this tracer is better at locating and attaching to lobular cancer cells than the standard of care tracer.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT04252859' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://lobularbreastcancer.org/imagingilc/' target='_blank'>Lobular Breast Cancer Alliance: Imaging and Lobular Breast Cancer</a> </li></ul>
NEAREST SITE: 2386 miles
Duke University Medical Center
Durham,NC
VISITS: 1 visit
PHASE: NA
NCT ID: NCT00734838
Optical Spectroscopy for Diagnosing Breast Cancer
Optical Spectroscopy During Breast Cancer Surgery and Core Needle Biopsy Scientific Title
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> Participants will be assigned to 1 of 2 diagnostic techniques based on their cancer status: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Scheduled for Surgery</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Optical spectroscopy for 5-10 minutes during the scheduled procedure </li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Scheduled for Biopsy</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Optical spectroscopy will be used on the tissue removed during the biopsy, and will require no additional time</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Optical spectroscopy uses special instruments and a low power light to identify cancerous cells in body tissue. </li> <li class="seamTextUnorderedListItem">It currently is used to detect a number of different types of cancer. </li> <li class="seamTextUnorderedListItem">To be eligible, individuals must be scheduled to have a mastectomy or lumpectomy, or be scheduled to have a biopsy because their mammogram suggests they have a high likelihood of having breast cancer.</li> </ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT00734838' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='http://www.uhnresearch.ca/tdc/documents/DO-7-1008MT.pdf' target='_blank'>UHN: Optical Breast Spectroscopy Overview</a> </li><li class='seamTextUnorderedListItem'><a href='http://www.pnas.org/content/98/8/4420.full.pdf' target='_blank'>PNAS: Optical Breast Spectroscopy</a> </li></ul>
